• Deep venous thrombosis
  • Rheumatic heart disease
  • Carisoprodol, Urine
  • Bone Morphogenetic Protein Receptor Type II (BMPR2) Gene Mutation Analysis
  • Factor XIII (F13A1) V34L Genetic Variation Analysis
  • Fluphenazine, Serum
  • Coxsackie A Virus Antobody, Serum
  • Lyme Disease (Borrelia burgdorferi) Antibody, IgG and IgM
  • Chromosome Analysis, Interphase, FISH
  • LiquidHALLMARK Multi Cancer Panel
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
Medical Test

Additional ICD10
Access to OncoExTra (Oncomap™ ExTra) for Metastatic Cancer is restricted.